Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Anti-Infectives Market: By Type: Antibacterial, Antifungal, Antiviral; By Route of Administration: Topical, Oral, Intravenous (IV), Others; By Distribution Channel: Hospital Pharmacy, Others; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Anti-Infectives Market Outlook
The global anti-infectives market attained a value of about USD 118.36 billion in 2021. The market is further expected to grow at a CAGR of 4.3% during the forecast period of 2022-2027 to reach nearly USD 152.37 billion by 2027.
Increasing Incidences of Infectious Diseases Boosting the Market Growth of Anti-Infectives
The rising prevalence of infectious diseases, particularly across the low- and middle-income countries, has led to a surge in demand for anti-infectives to curtail the spread of infection. This has been driving the market growth of anti-infectives.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
As a result of the increasing incidences of infectious agents, including bacteria, fungi, and viruses that are born from unhealthy environments lacking proper sanitation has led to the increasing incidences of diseases like diarrhoea, seasonal viral fevers, and skin infections, among others. Anti-infective agents act against the reproduction of the source of infection in the body over the course of time, and hence gradually killing the infection. Thus, the effectiveness of anti-infective agents is propelling the growth of the market.
Anti-Infectives: Industry Definition and Segmentation
Anti-infectives are medicines that are capable of restraining the spread of an infectious disease inside the body. These medicines can either be injected, consumed orally, or can be applied to the skin as ointments or creams.
On the basis of type, the market can be divided into:
- Antibacterial
- Antifungal
- Antiviral
Based on route of administration, the market can be categorised into:
- Topical
- Oral
- Intravenous (IV)
- Others
The market, based on distribution channel, can be segmented into:
- Hospital Pharmacy
- Retail Pharmacy
- Speciality Pharmacy
- Online
- Others
The EMR report looks into the regional markets of anti-infectives like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
Robust Investments into Research and Development (R&D) Invigorating the Market Growth of Anti-Infectives
The market for anti-infectives is rapidly growing due to the robust investments aimed at research and development (R&D) for the production of effective anti-infectives. Owing to the increasing antimicrobial resistance to existing anti-infective agents, the pharmaceutical sector is constantly innovating and researching to produce strong anti-infectives, which is augmenting the growth of the market. In addition, robust commercialisation schemes aimed at spreading knowledge about the existence of anti-infective agents in the market is furthering the market growth of anti-infectives. Moreover, the increasing awareness regarding the avoidable risks associated with early treatment of infectious diseases is further boosting the market growth of anti-infectives globally.
Key Industry Players in the Global Anti-Infectives Market
The report presents a detailed analysis of the following key players in the global anti-infectives market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions:
- Gilead Sciences, Inc.
- Sandoz International GmbH
- Pfizer Inc.
- GlaxoSmithKline plc.
- Abbott Laboratories
- Others
The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2021 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Route of Administration, Distribution Channel, Region |
| Breakup by Type | Antibacterial, Antifungal, Antiviral |
| Breakup by Route of Administration | Topical, Oral, Intravenous (IV), Others |
| Breakup by Distribution Channel | Hospital Pharmacy, Retail Pharmacy, Speciality Pharmacy, Online, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Gilead Sciences, Inc., Sandoz International GmbH, Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Anti-Infectives Market Analysis
8.1 Key Industry Highlights
8.2 Global Anti-Infectives Historical Market (2017-2021)
8.3 Global Anti-Infectives Market Forecast (2022-2027)
8.4 Global Anti-Infectives Market by Type
8.4.1 Antibacterial
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Antifungal
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Antiviral
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.5 Global Anti-Infectives Market by Route of Administration
8.5.1 Topical
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Oral
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Intravenous (IV)
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Others
8.6 Global Anti-Infectives Market by Distribution Channel
8.6.1 Hospital Pharmacy
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Retail Pharmacy
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Speciality Pharmacy
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2017-2021)
8.6.3.3 Forecast Trend (2022-2027)
8.6.4 Online
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2017-2021)
8.6.4.3 Forecast Trend (2022-2027)
8.6.5 Others
8.7 Global Anti-Infectives Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Gilead Sciences, Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Sandoz International GmbH
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Pfizer Inc.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 GlaxoSmithKline plc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Abbott Laboratories
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Anti-Infectives Market: Key Industry Highlights, 2017 and 2027
2. Global Anti-Infectives Historical Market: Breakup by Type (USD Million), 2017-2021
3. Global Anti-Infectives Market Forecast: Breakup by Type (USD Million), 2022-2027
4. Global Anti-Infectives Historical Market: Breakup by Route of Administration (USD Million), 2017-2021
5. Global Anti-Infectives Market Forecast: Breakup by Route of Administration (USD Million), 2022-2027
6. Global Anti-Infectives Historical Market: Breakup by Distribution Channel (USD Million), 2017-2021
7. Global Anti-Infectives Market Forecast: Breakup by Distribution Channel (USD Million), 2022-2027
8. Global Anti-Infectives Historical Market: Breakup by Region (USD Million), 2017-2021
9. Global Anti-Infectives Market Forecast: Breakup by Region (USD Million), 2022-2027
10. North America Anti-Infectives Historical Market: Breakup by Country (USD Million), 2017-2021
11. North America Anti-Infectives Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Europe Anti-Infectives Historical Market: Breakup by Country (USD Million), 2017-2021
13. Europe Anti-Infectives Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Asia Pacific Anti-Infectives Historical Market: Breakup by Country (USD Million), 2017-2021
15. Asia Pacific Anti-Infectives Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Latin America Anti-Infectives Historical Market: Breakup by Country (USD Million), 2017-2021
17. Latin America Anti-Infectives Market Forecast: Breakup by Country (USD Million), 2022-2027
18. Middle East and Africa Anti-Infectives Historical Market: Breakup by Country (USD Million), 2017-2021
19. Middle East and Africa Anti-Infectives Market Forecast: Breakup by Country (USD Million), 2022-2027
20. Global Anti-Infectives Market Structure
Key Questions Answered in the Report
The global anti-infectives market attained a value of nearly USD 118.36 billion in 2021.
The market is projected to grow at a CAGR of 4.3% in the forecast period of 2022-2027.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 152.37 billion by 2027.
The market is being driven by the rising prevalence of infectious diseases caused due to unhealthy environments, lack of proper sanitation, and unhygienic lifestyles.
Robust investments into the pharmaceutical sector for the development of advanced anti-infectives and growing awareness regarding the early treatment of infection is leading to the growth of the market.
The major regional markets for anti-infectives are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
The major types of anti-infectives are antibacterial, antifungal, and antiviral.
The different routes of administration are topical, oral, and intravenous (IV), among others.
The various distribution channels of anti-infectives are hospital pharmacy, retail pharmacy, speciality pharmacy, and online, among others.
The major players in the industry are Gilead Sciences, Inc., Sandoz International GmbH, Pfizer Inc., GlaxoSmithKline plc., and Abbott Laboratories, among others.
Analyst Review
The global anti-infectives market attained a value of about USD 118.36 billion in 2021, driven by the rising prevalence of infectious diseases. Aided by large scale investments into the pharmaceutical companies, the market is expected to grow at a CAGR of 4.3% in the forecast period of 2022-2027 to reach nearly USD 152.37 billion by 2027.
EMR’s meticulous research methodology delves deep into the market covering the macro and micro aspects of the industry. On the basis of type, the market can be divided into antibacterial, antifungal, and antiviral. Based on route of administration, the market can be categorised into topical, oral, and intravenous (IV), among others. The market, based on distribution channel, can be fragmented into hospital pharmacy, retail pharmacy, speciality pharmacy, and online, among others. The major regional markets for anti-infectives are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa. The key players in the industry are Gilead Sciences, Inc., Sandoz International GmbH, Pfizer Inc., GlaxoSmithKline plc., and Abbott Laboratories, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global vaccine market attained a value of nearly USD 57.55 billion in 2021, driven by the rising prevalence of chronic illnesses worldwide. Aided by the growing investments in the pharmaceutical i...
The global immunotherapy drugs market attained a value of nearly USD 179.6 billion in 2021, driven by the rising prevalence of cancer and other chronic illnesses worldwide. Aided by the growing invest...
The global anisole market attained a value of about USD 94.09 million in 2021, driven by the rising application of anisole in the pharmaceutical industry. Aided by the thriving e-commerce industry, th...
The global antiviral drugs market attained a value of more than USD 62.7 billion in 2021, driven by the rising cases of viral infections among the geriatrics, and rising healthcare expenditure. The ma...
The global oral antibiotics market attained a value of over USD 18,365.8 million in 2021, driven by the extensive use of oral antibiotics for the treatment of infectious diseases. Aided by the growing...
NEWSLETTER